Trial Profile
Phase I study of NLX-101 (F-15599) in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jun 2015
Price :
$35
*
At a glance
- Drugs F 15599 (Primary)
- Indications Rett syndrome
- Focus Adverse reactions
- Sponsors Neurolixis
- 11 Jun 2015 New trial record